Key details
Sponsor
Closed Joint-Stock Company NeoCor
Collaborators
CT Medical Limited Liability Company, Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Enrollment target
~2,000 participants
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
60 Years – 70 Years
Last updated September 2024